Integrating care coordination into telemedicine services provides a better patient experience than care coordination alone: Insights from a national neurodegenerative disease telemedicine program
Objective: To develop a comprehensive model of remote care for patients diagnosed with Parkinson’s disease (PD). Background: Recent data suggests that the incidence of new…Idiopathic Intracranial Hypertension as the presenting symptom in Wilson’s Disease: how is it possible?
Objective: To report a patient with Wilson’s disease (WD) who became symptomatic shortly after presenting Idiopathic Intracranial Hypertension (HII). Background: WD’s pleomorphic clinical phenotype remains…Bilateral Globus Pallidus Internus Deep Brain Stimulation in Progressive Dystonia in Mohr-Tranebjaerg Syndrome: Case Report and Review
Objective: We report a MTS patient genetically confirmed who presented with progressive generalized dystonia, deafness, and cognitive and behavioral abnormalities that were treated by internal…Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital
Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…Quantification of Striatal and Extrastriatal Dopamine Transporters with [18F]PR04.MZ and [18F] PI- 2620 PET in Patients with Progressive Supranuclear Palsy.
Objective: We aim to evaluate the differences in striatal subregional dopamine transporter loss between Parkinson disease (PD) and progressive supranuclear palsy (PSP) of any stage…Effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder
Objective: To evaluate the effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder (OAB) Background: There are many patients with OAB in…Transition among HD-ISS stages as an endpoint in clinical trials for HD
Objective: Investigate the time to the event of HD-ISS Stage 3 transition (functional change) as an endpoint for clinical trials in Huntington’s disease (HD) and…The study of genetic factors in levodopa-induced motor complications development in Russian patients with Parkinson’s disease
Objective: This study is aimed to explore the relationship between the single nucleotide polymorphisms (SNPs) in dopamine and serotonin metabolism genes, other neurotransmitter systems genes…Association Between Anticholinergic Burden, MCI, and Cholinergic Denervation
Objective: To characterize the relationship between anticholinergic burden (ACB), mild cognitive impairment (MCI), and its underlying cholinergic pathology. Background: MCI is a common phenomenon in…Design of a time-to-event study in GBA Parkinson’s Disease patients: Efficacy and safety of BIA 28-6156, an allosteric activator of beta-glucocerobridase (GCase)
Objective: To assess the efficacy of BIA 28-6156 in delaying clinically meaningful motor progression in PD patients who have a PD-risk associated variant in the…
- « Previous Page
- 1
- …
- 464
- 465
- 466
- 467
- 468
- …
- 1734
- Next Page »